Dermatology · Mountain View, CA
NPI
1346371382
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
701 E El Camino Real
Mountain View, CA, 94040
Phone (650) 934-7676
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
4,581 services
Medicare patients, 2024
438
Average age 76
Drug cost, 2024
$1.7M
1,661 prescriptions
Company payments, 2025
$550K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jenny E Murase was code 95044 (test - miscellaneous), 1,240 times for 15 patients. In total Jenny E Murase billed 4,581 services in 63 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95044 Test - Miscellaneous | Office | 1,240 | 15 | $5.19 | $6,431 |
| 17003 Destruction Skin Lesion | Office | 1,087 | 176 | $7.02 | $7,635 |
| 99213 Office E&M - Established | Office | 504 | 287 | $73.76 | $37K |
| 17000 Destruction Skin Lesion | Office | 375 | 223 | $49.00 | $18K |
| 99214 Office E&M - Established | Office | 318 | 159 | $114.40 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 182 | 99 | $14.71 | $2,677 |
| 17110 Destruction Skin Lesion | Office | 176 | 133 | $105.39 | $19K |
| 11102 Skin Biopsy | Office | 157 | 125 | $82.85 | $13K |
| 96900 Skin | Office | 75 | 18 | $27.29 | $2,047 |
| 11103 Skin Biopsy | Office | 56 | 43 | $48.62 | $2,723 |
| 96372 Injection Administration | Office | 45 | 30 | $13.78 | $620 |
| 99215 Office E&M - Established | Office | 42 | 38 | $149.99 | $6,299 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 36 | 15 | $0.78 | $28.12 |
| 11104 Skin Biopsy | Office | 32 | 32 | $128.93 | $4,126 |
| 11105 Skin Biopsy | Office | 21 | 14 | $60.06 | $1,261 |
By year: 2022 $202K for 5,187 services; 2023 $191K for 4,309 services; 2024 $187K for 4,581 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens | 17 | 17 | $16.96 | $288 |
Medicare prescription drug claims, 2024
In 2024, the drug Jenny E Murase prescribed most often to Medicare patients was Dupixent Syringe (Dupilumab), with 178 prescriptions and refills. In total Jenny E Murase wrote 1,661 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Syringe Dupilumab | 178 | 196 | 33 | $699K |
| Clobetasol Propionate Generic | 111 | 150 | 51 | $4,656 |
| Triamcinolone Acetonide Generic | 89 | 101 | 39 | $1,819 |
| Hydroxyzine Hcl Generic | 84 | 122 | 27 | $2,037 |
| Dupixent Pen Dupilumab | 66 | 72 | Under 11 | $256K |
| Fluocinonide Generic | 63 | 81 | 42 | $2,170 |
| Mupirocin Generic | 55 | 55 | 31 | $469 |
| Tacrolimus Generic | 55 | 66 | 31 | $5,164 |
| Gabapentin Generic | 45 | 45 | 11 | $553 |
| Minoxidil Generic | 43 | 76 | 11 | $566 |
| Ketoconazole Generic | 39 | 39 | 13 | $398 |
| Doxycycline Hyclate Generic | 36 | 40 | 12 | $1,228 |
| Pregabalin Generic | 36 | 40 | 13 | $1,168 |
| Desonide Generic | 34 | 40 | 24 | $1,453 |
| Terbinafine Hcl Generic | 33 | 43 | 14 | $144 |
Brand drugs: 403 claims; generic drugs: 1,258 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jenny E Murase $550K ($550K in general payments such as food, travel and fees) from 20 companies. The largest payer was Galderma Laboratories, L.P. with $151K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 136 | $151K |
| Genzyme Corporation SNY | 55 | $95K |
| Regeneron Healthcare Solutions, Inc. REGN | 84 | $92K |
| Lilly USA, LLC LLY | 92 | $82K |
| UCB, Inc. UCB.BR | 96 | $75K |
| LEO Pharma Inc. | 36 | $24K |
| Abbvie Inc. ABBV | 25 | $21K |
| Pfizer Inc. PFE | 11 | $6,207 |
| Sanofi US Services Inc. SNY | 1 | $2,870 |
| Allerderm Laboratories | 1 | $1,000 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.